KRISTEN FITZPATRICK: Open Payments
NPI 1487844239 · GARDEN CITY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,617 in 72 payments from 16 companies in 2025. Trend: 2023 $947 · 2024 $1,215 · 2025 $1,617
Food & beverage: $1,617
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $391 |
| Novartis Pharmaceuticals Corporation | 12 | $247 |
| UCB, Inc. | 6 | $182 |
| Regeneron Healthcare Solutions, Inc. | 6 | $127 |
| GENZYME CORPORATION | 5 | $114 |
| Janssen Biotech, Inc. | 4 | $89 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 3 | $77 |
| LEO Pharma Inc. | 4 | $74 |
| Organon LLC | 3 | $65 |
| Galderma Laboratories, L.P. | 3 | $63 |
Products named: SKYRIZI, DUPIXENT, COSENTYX, Bimzelx, TREMFYA, Cabtreo, ADBRY, TALTZ.
Industry payments across MI — which companies pay providers there.
